TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Myelodysplastic Syndrome
Research on myelodysplastic syndrome detailed by scientists at Erasmus University
January 13th, 2009
According to recent research from Netherlands, "Invasive aspergillosis (IA) is a leading cause of mortality in patients with acute leukemia. Management of IA is expensive, which makes prevention desirable." "Because hospital resources are limited, prevention costs have to be compared with treatment costs and outcome. In 269 patients treated for acute myelogenous leukemia-myelodysplastic syndrome (AML-MDS) during 2002-2007, evidence of IA was collected using high-resolution computed tomography and galactomannan measurement in bronchoalveolar lavage fluid specimens. IA was classified on the basis of updated European Organization for Research and Treatment of...
Source: TB & Outbreaks Week (2009-01-13)
|
